TCL Archive New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor. February 24, 2006
TCL Archive DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention July 18, 1980
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014